[{"address1": "331 Oyster Point Boulevard", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 481 6770", "website": "https://pliantrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of av\u00df6 and av\u00df1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of av\u00df1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins av\u00df8 and av\u00df1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 171, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bernard  Coulie M.B.A., M.D., Ph.D.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1078624, "exercisedValue": 0, "unexercisedValue": 4323229}, {"maxAge": 1, "name": "Dr. Keith Lamont Cummings M.B.A., M.D.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 713074, "exercisedValue": 234570, "unexercisedValue": 1088282}, {"maxAge": 1, "name": "Mr. Johannes P. Hull J.D.", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 654524, "exercisedValue": 0, "unexercisedValue": 1088204}, {"maxAge": 1, "name": "Dr. Eric A. Lefebvre M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 762338, "exercisedValue": 0, "unexercisedValue": 1232340}, {"maxAge": 1, "name": "Dr. Rik  Derynck Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dean  Sheppard M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  DeGrado Ph.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hal  Chapman M.D.", "title": "Scientific Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Delphine  Imbert Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher S. Keenan", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 9, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.37, "open": 1.35, "dayLow": 1.31, "dayHigh": 1.395, "regularMarketPreviousClose": 1.37, "regularMarketOpen": 1.35, "regularMarketDayLow": 1.31, "regularMarketDayHigh": 1.395, "payoutRatio": 0.0, "beta": 1.436, "forwardPE": -0.3358209, "volume": 2377953, "regularMarketVolume": 2377953, "averageVolume": 1778868, "averageVolume10days": 1333500, "averageDailyVolume10Day": 1333500, "bid": 1.33, "ask": 1.37, "bidSize": 5, "askSize": 5, "marketCap": 82871504, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 16.1, "fiftyDayAverage": 1.4262, "twoHundredDayAverage": 8.61375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -162599520, "profitMargins": 0.0, "floatShares": 54119370, "sharesOutstanding": 61386300, "sharesShort": 5038014, "sharesShortPriorMonth": 5089401, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.082100004, "heldPercentInsiders": 0.03042, "heldPercentInstitutions": 1.01276, "shortRatio": 7.23, "shortPercentOfFloat": 0.0841, "impliedSharesOutstanding": 61837600, "bookValue": 4.189, "priceToBook": 0.32227263, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -219515008, "trailingEps": -3.61, "forwardEps": -4.02, "enterpriseToEbitda": 0.698, "52WeekChange": -0.8879668, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 1.35, "targetHighPrice": 47.0, "targetLowPrice": 1.5, "targetMeanPrice": 10.0625, "targetMedianPrice": 3.0, "recommendationMean": 2.75, "recommendationKey": "hold", "numberOfAnalystOpinions": 8, "totalCash": 305644992, "totalCashPerShare": 4.979, "ebitda": -232848000, "totalDebt": 60174000, "quickRatio": 10.897, "currentRatio": 11.034, "debtToEquity": 23.399, "returnOnAssets": -0.33892, "returnOnEquity": -0.63216, "freeCashflow": -112836752, "operatingCashflow": -174096000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "messageBoardId": "finmb_325980525", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "exchange": "NMS", "corporateActions": [], "postMarketTime": 1748638657, "regularMarketTime": 1748635201, "market": "us_market", "shortName": "Pliant Therapeutics, Inc.", "longName": "Pliant Therapeutics, Inc.", "regularMarketChangePercent": -1.45985, "regularMarketPrice": 1.35, "epsForward": -4.02, "epsCurrentYear": -2.46921, "priceEpsCurrentYear": -0.5467336, "fiftyDayAverageChange": -0.07620001, "fiftyDayAverageChangePercent": -0.053428695, "twoHundredDayAverageChange": -7.2637506, "twoHundredDayAverageChangePercent": -0.8432739, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-03", "averageAnalystRating": "2.8 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591191000000, "postMarketChangePercent": 3.7037, "postMarketPrice": 1.4, "postMarketChange": 0.05, "regularMarketChange": -0.02, "regularMarketDayRange": "1.31 - 1.395", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1778868, "fiftyTwoWeekLowChange": 0.25, "fiftyTwoWeekLowChangePercent": 0.22727272, "fiftyTwoWeekRange": "1.1 - 16.1", "fiftyTwoWeekHighChange": -14.75, "fiftyTwoWeekHighChangePercent": -0.916149, "fiftyTwoWeekChangePercent": -88.796684, "earningsTimestamp": 1746734703, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.61, "displayName": "Pliant Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]